Cite
Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
MLA
Nian, Fulin, et al. “Gut Microbiota Metabolite TMAO Promoted Lipid Deposition and Fibrosis Process via KRT17 in Fatty Liver Cells in Vitro.” Biochemical & Biophysical Research Communications, vol. 669, Aug. 2023, pp. 134–42. EBSCOhost, https://doi.org/10.1016/j.bbrc.2023.05.041.
APA
Nian, F., Zhu, C., Jin, N., Xia, Q., Wu, L., & Lu, X. (2023). Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro. Biochemical & Biophysical Research Communications, 669, 134–142. https://doi.org/10.1016/j.bbrc.2023.05.041
Chicago
Nian, Fulin, Chen Zhu, Nuyun Jin, Qiaoyun Xia, Longyun Wu, and Xiaolan Lu. 2023. “Gut Microbiota Metabolite TMAO Promoted Lipid Deposition and Fibrosis Process via KRT17 in Fatty Liver Cells in Vitro.” Biochemical & Biophysical Research Communications 669 (August): 134–42. doi:10.1016/j.bbrc.2023.05.041.